Lima SM et al (2021) Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinMedicine 38:100985

Article  Google Scholar 

Al-Mahmood S et al (2018) Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res 8(5):1483–1507

Article  PubMed  PubMed Central  Google Scholar 

Finn RS et al (2016) Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers. Breast Cancer Res 18(1):17

Article  PubMed  PubMed Central  Google Scholar 

Tosello G et al (2018) Breast surgery for metastatic breast cancer. Cochrane Database System Rev 3:CD011276

Slamon DJ et al (2020) Overall survival with Ribociclib plus fulvestrant in advanced breast cancer. New Eng J Med 382(6):514–524

Article  CAS  PubMed  Google Scholar 

Shah A et al (2018) FDA approval: Ribociclib for the treatment of postmenopausal women with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. Clin Cancer Res 24(13):2999–3004

Article  CAS  PubMed  Google Scholar 

Arora S et al (2017) Project ECHO: an effective means of increasing palliative care capacity. Am J Manag Care 23(7):SP267–SP271

Liu D et al (2016) The smart drug delivery system and its clinical potential. Theranostics 6(9):1306–1323

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hurler J et al (2013) The effect of lipid composition and liposome size on the release properties of liposomes-in-hydrogel. Int J Pharm 456(1):49–57

Article  CAS  PubMed  Google Scholar 

Guimarães D et al (2021) Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm 601:120571

Article  PubMed  Google Scholar 

Yin Y et al (2022) Choline-induced SLC5A7 impairs colorectal cancer growth by stabilizing p53 protein. Cancer Let 525:55–66

Article  CAS  Google Scholar 

Gynther M et al (2010) Brain uptake of ketoprofen-lysine prodrug in rats. Int J Pharm 399(1–2):121–128

Article  CAS  PubMed  Google Scholar 

Wu W et al (2015) Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors. Cancer Sci 106(6):747–756

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shennan DB et al (2004) L-Leucine transport in human breast cancer cells (MCF-7 and MDA-MB-231): Kinetics, regulation by estrogen and molecular identity of the transporter. Biochim et Biophy Acta - Biomembranes 1664(2):206–216

Article  CAS  Google Scholar 

Metselaar JM et al (2003) A novel family of l-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. Bioconjug Chem 14(6):1156–1164

Article  CAS  PubMed  Google Scholar 

Li L et al (2016) Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting. Colloid Surf B: Biointerf 141:260–267

Article  CAS  Google Scholar 

Li L et al (2017) Targeting tumor highly-expressed LAT1 transporter with amino acid-modified nanoparticles: Toward a novel active targeting strategy in breast cancer therapy. Nanomed Nanotech Biol Med 13(3):987–998

Article  CAS  Google Scholar 

Wang Z et al (2019) Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB0,+ for efficient tumor therapy. J Control Rel 316:22–33

Article  CAS  Google Scholar 

Brandl M (2001) Liposomes as drug carriers: A technological approach. Biotechnol Annu Rev 7:59–85

Article  CAS  PubMed  Google Scholar 

Pinto F et al (2018) Design of multifunctional nanostructured lipid carriers enriched with α-tocopherol using vegetable oils. Ind Crops Product 118:149–159

Article  CAS  Google Scholar 

Kępczyński M et al (2008) Which physical and structural factors of liposome carriers control their drug-entrapment efficiency. Chem Phys Lipid 155(1):7–15

Zhao L et al (2015) Preparation of liposomes using supercritical carbon dioxide technology: Effects of phospholipids and sterols. Food Res Int 77:63–72

Article  CAS  Google Scholar 

Hua S, Wu SY (2013) The use of lipid-based nanocarriers for targeted pain therapies. Front Pharmacol 4:143

Article  PubMed  PubMed Central  Google Scholar 

Accardo A, Morelli G (2015) Peptide-targeted liposomes for selective drug delivery: advantages and problematic issues. Biopolymers 104(5):462–479

Article  CAS  PubMed  Google Scholar 

Hong SS et al (2015) Effects of triglycerides on the hydrophobic drug loading capacity of saturated phosphatidylcholine-based liposomes. Int J Pharm 483(1–2):142–150

Article  CAS  PubMed  Google Scholar 

Kaddah S et al (2018) Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Food Chem Toxicol 113:40–48

Article  CAS  PubMed  Google Scholar 

Luo Q et al (2016) Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB°+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy. J Control Rel 243:370–380

Article  CAS  Google Scholar 

Kim CK, Park DK (1987) Stability and drug release properties of liposomes containing cytarabine as a drug carrier. Arch Pharm Res 10(2):75–79

Article  Google Scholar 

Papageorgiou F et al (2019) Physicochemical study of the protein–liposome interactions: influence of liposome composition and concentration on protein binding. J Liposome Res 29(4):313–321

Article  Google Scholar 

Arnida et al (2011) Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77(3):417–423

Article  CAS  PubMed  Google Scholar 

Sartaj A et al (2022) Ribociclib nanostructured lipid carrier aimed for breast cancer: formulation optimization, attenuating in vitro specification, and in vivo scrutinization. BioMed Res Int 2022:6009309

Article  PubMed  PubMed Central  Google Scholar 

Nakanishi T et al (2011) Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy. J Pharm Sci 100(9):3731–3750

Article  CAS  PubMed  Google Scholar 

Salatin S et al (2015) Effect of the surface modification, size, and shape on cellular uptake of nanoparticles. Cell Biol Int 39(8):881–890

Article  CAS  PubMed  Google Scholar 

Dickson MA (2014) Molecular pathways: CDK4 inhibitors for cancer therapy. Clin Cancer Res 20(13):3379–3383

Article  CAS  PubMed  Google Scholar 

Kommineni N et al (2022) Stealth liposomal chemotherapeutic agent for triple negative breast cancer with improved pharmacokinetics. Nanotheranostics 6(4):424–435

Article  PubMed  PubMed Central  Google Scholar 

Al-Shdefat R et al (2023) Ribociclib hybrid lipid–polymer nanoparticle preparation and characterization for cancer treatment. Polymers 15(13):2844

Article  CAS  PubMed  PubMed Central  Google Scholar